Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 14, 2005; 11(26): 4052-4060
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4052
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4052
Figure 5 Western blot analysis of COX-1 and COX-2protein expression in gastric mucosal lysates obtained from animals treated with indomethacin (IND), lansoprazole (LAN, 90 µmol/kg) or lansoprazole plus indomethacin (LAN+IND).
aP < 0.05 vs the control values (CON).
- Citation: Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, Antonioli L, Lazzeri G, Tacca MD. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 2005; 11(26): 4052-4060
- URL: https://www.wjgnet.com/1007-9327/full/v11/i26/4052.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i26.4052